These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11081391)

  • 1. T cell lymphoproliferative disorder following bone marrow transplantation for severe aplastic anemia.
    Wang LC; Lu MY; Yu J; Jou ST; Chiang IP; Lin KH; Lin DT
    Bone Marrow Transplant; 2000 Oct; 26(8):893-7. PubMed ID: 11081391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission of a lymphoproliferative disorder occurring after second BMT from an unrelated donor in a 5-year-old boy with severe aplastic anemia.
    Bader P; Klingebiel T; Klingel K; Föll J; Beck J; Handgretinger R; Ehninger G; Deeg HJ; Niethammer D
    Bone Marrow Transplant; 1995 Sep; 16(3):479-81. PubMed ID: 8535324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal post-transplant lymphoproliferative disorder following allogeneic bone marrow transplantation for aplastic anemia.
    Rudzki Z; Werda L; Piatkowska-Jakubas B; Mensah P; Zazula M; Białas M; Skotnicki AB; Stachura J
    Pol J Pathol; 2002; 53(1):35-40. PubMed ID: 12014224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.
    Micallef IN; Chhanabhai M; Gascoyne RD; Shepherd JD; Fung HC; Nantel SH; Toze CL; Klingemann HG; Sutherland HJ; Hogge DE; Nevill TJ; Le A; Barnett MJ
    Bone Marrow Transplant; 1998 Nov; 22(10):981-7. PubMed ID: 9849695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-transplant EBV-associated lymphoproliferative disorders--report of two cases].
    Iwami H; Misawa A; Tsunamoto K; Kasubuchi Y; Naya M; Hojo M; Goto T; Hibi S; Matsumura T; Todo S; Imashuku S
    Rinsho Ketsueki; 1998 Mar; 39(3):198-204. PubMed ID: 9577643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
    Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia.
    Dufour C; Dallorso S; Casarino L; Corcione A; Pistoia V; Bacigalupo A; Morreale G; Dini G
    Bone Marrow Transplant; 1999 Apr; 23(7):743-5. PubMed ID: 10218856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-related post-transplant lymphoproliferative disorder occurring after bone marrow transplantation for aplastic anemia in Down's syndrome.
    Furuya A; Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2014; 7(1):438-42. PubMed ID: 24427369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
    Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
    Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F
    Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
    Kang HJ; Shin HY; Choi HS; Ahn HS
    Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation.
    Aisa Y; Mori T; Nakazato T; Suzuki S; Suzuki N; Ikeda Y; Okamoto S
    Transpl Infect Dis; 2009 Oct; 11(5):438-41. PubMed ID: 19497045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.
    Novitzky N; Thomas V; Stubbings H; Hale G; Waldmann H
    Cytotherapy; 2004; 6(5):450-6. PubMed ID: 15512911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up and outcome.
    Perkins JL; Neglia JP; Ramsay NK; Davies SM
    Bone Marrow Transplant; 2001 Sep; 28(5):523-6. PubMed ID: 11593328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus associated post-transplantation lymphoproliferative disorder with hemophagocytosis in a child with Wiskott-Aldrich syndrome.
    Wang IJ; Lu MY; Chiang BL; Lin WC; Lin DT; Lin KH
    Pediatr Blood Cancer; 2005 Sep; 45(3):340-3. PubMed ID: 15547918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.